Anti-TNF-alpha for treatment of amyloidosis associated with Crohn's disease.
Fernández-Nebro
A
A
Ureña
I
I
Irigoyen
M V
MV
García-Vicuña
R
R
D000328:Adult; D000686:Amyloidosis / Q000188:drug therapy*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003424:Crohn Disease / Q000150:complications*; D017809:Fatal Outcome; D006801:Humans; D000069285:Infliximab; D008297:Male; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D000911:Antibodies, Monoclonal; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab